Dalao, Victor A.
HRN: 10-74-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 750MG (VIAL)
06/05/2022
06/12/2022
IV
700mg
Q8
Straddle Injury
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes